Palliative pelvic exenteration using iliofemoral bypass with synthetic grafts for advanced cervical carcinoma

Creative Commons License

Tatar B., Yalcin Y., ERDEMOĞLU E.

TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol.16, no.1, pp.80-83, 2019 (ESCI) identifier identifier identifier


Objective: Recurrent cervical cancer can cause severe morbidity. Despite the severe morbidity after surgery, pelvic exenteration is still used today for mainly curative intent. This intention is neither based on randomized controlled trials (RCTs) nor high quality non-RCTs with adequate patient numbers comparing medical management with surgery. The same is true for exenteration for palliative intent, so the patient selection for either curative or palliative intent must be considered on a patient-by-patient basis.